Update on hemangiomas and vascular malformations

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 6, 2004, Pages 476-487

  Buckmiller, Lisa M ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Arteriovenous malformations; Capillary hemangioma; Cystic hygroma; Hemangiomas; Lymphangioma; Lymphatic malformations; Vascular anomalies; Vascular malformations; Venous malformations

Indexed keywords

BETAMETHASONE; HYDROCORTISONE; IMIQUIMOD; RECOMBINANT INTERFERON; STEROID; TRIAMCINOLONE; VINCRISTINE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; CAPILLARY HEMANGIOMA; CLINICAL TRIAL; CONGENITAL BLOOD VESSEL MALFORMATION; CUSHINGOID SYNDROME; CYSTIC LYMPHANGIOMA; DISEASE CLASSIFICATION; ELECTROCOAGULATION; GROWTH RETARDATION; HEMANGIOMA; HUMAN; KASABACH MERRITT SYNDROME; LASER SURGERY; LIVER HEMANGIOMA; LYMPHANGIOMA; LYMPHATIC SYSTEM DISEASE; PATHOGENESIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCLEROTHERAPY; SPASTIC PARESIS; VEIN MALFORMATION;

ARTERIOVENOUS MALFORMATIONS; CHILD; COMBINED MODALITY THERAPY; GLUCOCORTICOIDS; HEMANGIOMA; HUMANS; LASER COAGULATION; LASER SURGERY; LIVER NEOPLASMS; ORBITAL NEOPLASMS; SCLEROTHERAPY;

EID: 9444274030     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000145946.67222.01     Document Type: Review

References (67)

1. Mulliken JB, Glowacki J: H emangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982, 69:412-420.
2. Finn MC, Glowacki J, Mulliken JB: Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983, 18:894-899.
3. Low DW: Management of adult facial vascular anomalies. Facial Plast Surg 2003, 19:113-129. Excellent review article.
4. Van Aalst JA, Bhuller A, Sadove AM: Pediairic vascular lesions. J Craniofao Surg 2003, 14:566-583.
5. Brucker AL, Frieden IJ: Hemangiomas of infancy. J Am Acad Dermatol 2003, 48:477-493. Good review and update on the research and treatment of hemangiomas.
6. Greene AK, Rogers GF, Mulliken JB: Management of parotid hemangiomas in 100 children. Plast Reconstr Surg 2004, 113:53-60.
7. North PE, Waner M, Mizeraki A, Mihm MC: GLUT 1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000, 31:11-22. Landmark article linking hemangiomas to placental tissue and improved diagnostic capability.
8. Mo JQ, Dimashkieh HH, Bove KE: GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004, 35:200-209.
9. Nguyen VA, Furhapter C, Romani N, et al.: Infantile hemangioma is a proliferation of β4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol 2004, 35:739-744.
10. Blei F, Walter J, Orlow SJ, Marchuk DA: Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998, 134:718-722.
11. Hasan Q, Tan ST, Xu B, Davis PF: Effects of five commonly used glucocorticoids on hemangioma in vitro. Clin Exp Pharmacol Physiol 2003, 30:140-144. Demonstrates the efficacy of different glucocorticoids on hemangiomas in vitro.
12. Egbert JE, Paul S, Engel K, Summers CG: High injection pressure during intralesional injection of corticosteriods into capillary hemangiomas. Arch Ophthalmol 2001, 119:677-683.
13. Fawcett SL, Grant I, Hall PN, et al.: Vincristine as a treatment for a large haemangioma threatening vital functions. The British Association of Plastic Surgeons. Br J Plast Surg 2004, 57:168-171. Vincristine as an important alternative to more toxic interferon in the treatment of large hemangiomas.
14. Sidbury R, Neuschier N, Neuschier E, et al.: Topically applied imiquimod inhibits vascular tumor growth in vivo. J Invest Dermatol 2003, 121:1205-1209. Promising new topical agent for treatment of hemangiomas.
15. Berman B, Poochareon VN, Villa AM: Novel dermatologic uses of the immune response modifier imiquimod 5% cream. Skin Therapy Lett 2002, 7:1-10.
16. David LR, Malek MM, Argenta LC: Efficacy of pulse dye laser therapy for the treatment of ulcerated hemangiomas: a review of 78 patients. The British Association of Plastic Surgeons. Br J Plast Surg 2003, 56:317-327.
17. Batta K, Goodyear HM, Moss C, et al.: Randomized controlled study of early pulsed dye laser treatment of uncomplicated childhood hemangiomas: results of a 1 year analysis. Lancet 2002, 360:521-527.
18. Middlekamp-Hup MA, Sanchez-Carpintero I, Anderson RR, et al.: Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model. J of Investig Derm 2003, 121:634-639.
19. Agesta N, Boralevi F, Learte-Labreze C: Life-threatening hemorrhage as a complication of congenital hemangioma. Acta Paediatr 2003, 92:1216-1222.
20. Berenguer B, De Salamance JE, Perez A, et al.: Large involuted facial hemangioma treated with syringe liposuction. Plast Reconstr Surg 2003, 111:314-318. Good article describing treatment of involuted hemangioma with residual fibrofatty tissue with liposuction.
21. Hughes JA, Hill V, Patel K, et al.: Cutaneous hemangioma: prevalence and sonographic characteristics of associated hepatic hemangioma. Clin Radiol 2004, 59:273-280.
22. Kasserjian A, Zurakowski D, Burrows PE, et al.: Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 2004, 182:785-795.
23. Kasahara M, Kiuchi T, Tanaka K, et al.: Monosegmental Living-Donor Liver Transplantation for Infantile Hepatic Hemangioendothelioma. J Pediatr Surg 2003, 38:1108-1111.
24. Ceisler EJ, Santos L, Blei F: Periocular hemangiomas: what every physician should know. Pediatr Dermatol 2004, 21:1-9. Presents a good algorithm for treatment of periocular hemangiomas.
25. O'Keefe M, Lanigan B, Byrne SA: Capillary hemangioma of the eyelids and orbit: a clinical review of the safety and efficacy of intralesional steroid. Acta Ophthalmol Scand 2003, 81:294-298. Demonstrates widespread use of intralesional injection for periocular hemangiomas.
26. Goyal R, Watts P, Gregory JW, et al.: Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma. Ophthalmology 2004, 111:389-395.
27. Coats DK, O'Neil JW, Paysse EA, et al.: SubTenon's infusion of steroids for treatment of orbital hemangiomas. Ophthalmology 2003, 110:1255-1259.
28. Wasserman BN, Medow NB, Hoehn ME: Treatment of periocular capillary hemangiomas. J AAPOS 2004, 8:175-181. Survey of ophthalmologists showing that intralesional injection was the most commonly used treatment modality but warning about possible complications.
29. 2 laser surgery in the treatment of congenital infantile subglottic hemangioma: experience in the Department of Otolaryngology, "Sick Children Hospital", Toronto, Canada. Acta Otorhinolaryngol Ital 2003, 23:175-179.
30. 2 laser therapy versus tracheostomy. Int J Pediatr Otorhinolaryngol 2002, 64:143-157.
31. Wang LY, Hung HY, Lee KS: Infantile subglottic hemangioma treated by intralesional steroid injection: report of one case. Acta Paediatr Taiwan 2003, 44:35-37.
32. Naiman AN, Ayari S, Froehlich P: Controlled risk of stenosis after surgical excision of laryngeal hemangioma. Arch Otolaryngol Head Neck Surg 2003, 129:1291-1295.
33. Cooper JG, Edwards SL, Holmes JD: Kaposiform hemangioendothelioma: case report and review of the literature. Br J Plast Surg 2002, 55:163-165.
34. Wong SN, Tay YK: Tufted angioma: a report of five cases. Pediatr Dermatol 2002, 19:388-393.
35. Wananukul S, Nuchprayoon I, Seksarn P: Treatment of Kasabach-Merritt syndrome: a stepwise regimen of prednisone, dipyridamole, and interferon. Int J Dermatol 2003, 42:741-748.
36. Haisley-Royster C, Enjolras O, Adams DM, et al.: Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 2002, 24:459-462.
37. Rinker B, Karp NS, Rofsky NM, et al.: The role of magnetic resonance imaging in the management of vascular malformations of the trunk and extremities. Plast Reconstr Surg 2003, 112:504-510.
38. Hein KD, Mulliken JB, Burrows PE, et al.: Venous malformations of skeletal muscle. Plast Reconstr Surg 2002, 100:1625-1635.
39. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB: Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999, 104:1-11.
40. Pappas DC, Persky MS, Berenstein A: Evaluation and treatment of head and neck venous vascular malformations. Ear Nose Throat J 1998, 77:914-916, 918-922.
41. Puig S, Aref H, Brunelle F, et al.: Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol 2003, 33:99-103.
42. Cabrera J, Cabrera J, Garcia-Olmedo A, Redondo P: Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003, 139:1409-1416. Important new treatment modality usind Microfoam sclerotherapy; effectiveness was noted in KTS patients and the treatment should be considered a breakthrough.
43. Mimura H, Kanazawa S, Hiraki Y, et al.: Percutaneous sclerotherapy for venous malformations using polidocanol under fluorocopy. Acta Med Okayama 2003, 57:227-234.
44. Chang CJ, Fisher DM, Chen YR: Intralesional photocoagulation of vascular anomalies of the tongue. Br J Plast Surg 1999, 52:178-181.
45. Glaessl A, Schreyer AG, Hohenleutner U, et al.: Laser surgical planning with magnetic resonance imaging-based 3-dimensional reconstructions for intralesional Nd:YAG laser therapy of a venous malformation of the neck. Arch Dermatol 2001, 137:1331-1335.
46. Groot D, Rao J, Johnston P, Nakatsui T: Algorithm for using a long-pulsed Nd:YAG laser in the treatment of deep cutaneous vascular lesions. Dermatol Surg 2003, 29:35-42. Good review algorithm for treatment of surface discoloration using long pulsed Nd:YAG laser (altus).
47. Naidu SI, McCalla M: Lymphatic malformations of the head and neck in adults: a case report and review of the literature. Ann Otol Rhinol Laryngol 2004, 113:218-222.
48. Giguere CM, Bauman NM, Smith RJH: New treatment options for lymphangioma in infants and children. Ann Otol Rhinol Laryngol 2002, 111:1066-1075.
49. Long AEB, Brown K: Lymphatic malformations. J La State Med Soc 2003, 155:302-305.
50. Fujino A, Moriya Y, Kitajima M, et al.: A Role of cytokines in OK-432 injection therapy for cystic lymphangioma: an approach to the mechanism. J Pediatr Surg 2003, 38:1806-1809.
51. Banieghbal B, Davies MRQ: Guidelines for the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg 2003, 13:103-107.
52. Hall N, Ade-Ajai N, Pierro A, et al.: Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? Surgery 2003, 133:238-242.
53. Muir R, Kirsten M, Ionescu GO, et al.: Intralesional bleomycin injection treatment for hemangiomas and congenital vascular malformations. Pediatr Surg Int 2004, 19:766-773. Good treatment option; no incidence of pulmonary fibrosis.
54. Karam A, Ianotto JC, Berthou C, et al.: In-column electrocoagulation for lymphatic malformation of the tongue. Br J Dermatol 2003, 148:1270-1290.
55. Suarez-Cunqueiro MM, Gutwald R, Schnelzeisen R, et al.: Arteriovenous malformation in the temporalis muscle. Br J Oral Maxillofac Surg 2003, 41:277-279.
56. Lanzino G, Passacantilli E, Spetzler RF, et al.: Scalp arteriovenous malformation draining into the superior sagittal sinus associated with an intracranial arteriovenous malformation: just a coincidence? Case report. Neurosurgery 2003, 52:440-443.
57. Lam SM, Dahiya R, Williams EP: Management of an arteriovenous malformation. Arch Facial Plast Surg 2003, 5:334-337.
58. Khong PL, Burrows PE, Kozakewich HP, Mulliken JB: Fast-flow lingual vascular anomalies in the young patient: is imaging diagnostic? Pediatr Radiol 2003, 33:118-122. Describes atypical MRI findings for AVMs.
59. Sreevathsa MR, Lalitha RM, Prasad K: Arteriovenous malformations of the head and neck: experience with magnetic resonance angiography and therapeutic embolisation. Br J Oral Maxillofac Surg 2003, 41:75-77.
60. Lee BB, Do YS, Yakes W, et al.: Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 2004, 39:590-600. Good review, multidisciplinary team approach to management of AVM.
61. Lookstein RA, Guller J: Embolization of complex vascular lesions. Mt Sinai J Med 2004, 71:17-28. Good review of embolization for vascular anomalies as well as other vascular problems.
62. Rockman CB, Rosen RJ, Riles TS, et al.: Transcatheter embolization of extremity malformations: the long-term success of multiple interventions. Ann Vasc Surg 2003, 17:417-423.
63. Giaoui L, Princ G, Bertrand JC, et al.: Treatment of vascular malformations of the mandible: a description of 12 cases. Int J Oral Maxillofac Surg 2003, 32:132-136.
64. Yoshiga K, Tanimoto K, Okui T, Kobayashi M: High-flow arteriovenous malformation of the mandible: treament and 7-year follow-up. Br J Oral Maxillofac Surg 2003, 41:348-350.
65. Kademani D, Costello BJ, Quinn P, et al.: An alternative approach to maxiliofacial arteriovenous malformations with transosseous direct puncture embolization. Oral Surg Oral Med Oral Pathol 2004, 97:701-706. Presents embolization as an alternative for treating intraosseous component of AVM.
66. Persky MS, Yoo HJ, Berenstein A: Management of vascular malformations of the mandible and maxilla. Laryngoscope 2003, 113:1885-1892. Also studies embolization/surgery for control of intraosseous vascular malformations, with prognosis being influenced by location; there is a better prognosis for mandible lesions than maxillary.
67. Cokluk C, Lyigun O, Rakunt C, et al.: The Guidance of intraoperative ultrasonography in the surgical treatment of arteriovenous malformation. Minim Invasive Neurosurg 2003, 46:169-172. May be an important technique to consider for intraoperative definition of the nidus.